000142900 001__ 142900
000142900 005__ 20240229112534.0
000142900 0247_ $$2doi$$a10.1007/s00441-018-2899-6
000142900 0247_ $$2pmid$$apmid:30069597
000142900 0247_ $$2ISSN$$a0044-3794
000142900 0247_ $$2ISSN$$a0302-766X
000142900 0247_ $$2ISSN$$a0340-0336
000142900 0247_ $$2ISSN$$a0373-031X
000142900 0247_ $$2ISSN$$a1432-0878
000142900 0247_ $$2altmetric$$aaltmetric:45980862
000142900 037__ $$aDKFZ-2019-00530
000142900 041__ $$aeng
000142900 082__ $$a610
000142900 1001_ $$00000-0003-2847-0859$$aLefevre, Arthur$$b0$$eFirst author
000142900 245__ $$aImaging neuropeptide effects on human brain function.
000142900 260__ $$aHeidelberg$$bSpringer$$c2019
000142900 3367_ $$2DRIVER$$aarticle
000142900 3367_ $$2DataCite$$aOutput Types/Journal article
000142900 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1551190563_32560$$xReview Article
000142900 3367_ $$2BibTeX$$aARTICLE
000142900 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142900 3367_ $$00$$2EndNote$$aJournal Article
000142900 520__ $$aThe discovery of prosocial effects of oxytocin (OT) opened new directions for studying neuropeptide effects on the human brain. However, despite obvious effects of OT on neural responses as reported in numerous studies, other peptides have received less attention. Therefore, we will only briefly summarize evidence of OT effects on human functional magnetic resonance imaging (fMRI) and primarily focus on OT's sister neuropeptide arginine-vasopressin by presenting our own coordinated-based activation likelihood estimation meta-analysis. In addition, we will recapitulate rather limited data on few other neuropeptides, including pharmacological and genetic fMRI studies. Finally, we will review experiments with external neuropeptide administration to patients afflicted with mental disorders, such as autism or schizophrenia. In conclusion, despite remaining uncertainty regarding the penetrance of exogenous neuropeptides through the blood-brain barrier, it is evident that neuropeptides simultaneously influence the activity of limbic and cortical areas, indicating that these systems have a good potential for therapeutic drug development. Hence, this calls for further systematic studies of a wide spectrum of known and less known neuropeptides to understand their normal function in the brain and, subsequently, to tackle their potential contribution for pathophysiological mechanisms of mental disorders.
000142900 536__ $$0G:(DE-HGF)POF3-319H$$a319H - Addenda (POF3-319H)$$cPOF3-319H$$fPOF III$$x0
000142900 588__ $$aDataset connected to CrossRef, PubMed,
000142900 7001_ $$aHurlemann, Rene$$b1
000142900 7001_ $$0P:(DE-He78)b2142a2557ce071790760d0126e259d3$$aGrinevich, Valery$$b2$$eLast author$$udkfz
000142900 773__ $$0PERI:(DE-600)1458496-7$$a10.1007/s00441-018-2899-6$$gVol. 375, no. 1, p. 279 - 286$$n1$$p279 - 286$$tCell & tissue research$$v375$$x1432-0878$$y2019
000142900 909CO $$ooai:inrepo02.dkfz.de:142900$$pVDB
000142900 9101_ $$0I:(DE-588b)2036810-0$$60000-0003-2847-0859$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142900 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b2142a2557ce071790760d0126e259d3$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000142900 9131_ $$0G:(DE-HGF)POF3-319H$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vAddenda$$x0
000142900 9141_ $$y2019
000142900 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000142900 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELL TISSUE RES : 2017
000142900 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142900 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142900 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142900 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000142900 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000142900 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142900 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000142900 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142900 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142900 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000142900 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000142900 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000142900 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000142900 9201_ $$0I:(DE-He78)V078-20160331$$kV078$$lAG Neuropeptide$$x0
000142900 980__ $$ajournal
000142900 980__ $$aVDB
000142900 980__ $$aI:(DE-He78)V078-20160331
000142900 980__ $$aUNRESTRICTED